Company: SRPT
Filing Date: 2025-05-06
Form Type: 10-Q
Source: 0000950170-25-064412
Chunk: 3

Company: Sarepta Therapeutics, Inc.
Filing Date: 2025-05-06
Form: 10-Q
Item: Part II, Item 3
Chunk 3
---
None. 

Item 4. Mine Safety Disclosures. 

None. 

Item 5. Other Information. 

During the three months ended March 31, 2025, no director or officer (as defined in Rule 16a-1(f) under the Exchange Act) of the Company adopted or terminated contracts, instructions or written plans for the purchase or sale of our securities that are intended to satisfy the conditions specified in Rule 10b5-1(c) under the Exchange Act for an affirmative defense against liability for trading in securities on the basis of material nonpublic information. 

Item 6. Exhibits. 

The exhibits listed on the Exhibit Index immediately preceding such exhibits, which is incorporated herein by reference, are filed or furnished as part of this Quarterly Report on Form 10-Q.